尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Wanstok Philippe, 管理人员. Director active across 1 company, notably MicroPort CardioFlow Medtech Corporation - B. Aggregated, 3 reports have been recorded. History available since 21 April 2026. The latest transaction was filed on 22 April 2026 (Sale). Regulator: HKEX. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
WANSTOK PHILIPPE is an executive at MicroPort CardioFlow Medtech Corporation - B. He is involved in the strategic management of the company, which focuses on medical technologies. His role is crucial for developing innovative solutions and expanding the company's presence in the market.